https://ablinc.com/about-abl/news/news-item/news-item-test/ 2016-04-28T15:08:46+00:00 https://ablinc.com/about-abl/news/news-item/abl-part-team-awarded-900-million-idiq-contract-u-s-army-medical-product-research-development/ 2016-04-28T15:17:37+00:00 https://ablinc.com/about-abl/news/news-item/abl-recognized-supporting-fill-finish-novavaxs-zaire-ebolavirus-glycoprotein-nanoparticle-vaccine/ 2016-04-28T15:20:52+00:00 https://ablinc.com/about-abl/news/news-item/abl-selected-support-glioblastoma-multiforme-trial-clinical-testing-services/ 2016-04-28T15:24:55+00:00 https://ablinc.com/about-abl/news/news-item/abl-successfully-completes-drug-product-manufacture-ebola-vaccine-clinical-trial/ 2016-04-28T15:26:57+00:00 https://ablinc.com/about-abl/news/news-item/abl-inc-launches-virus-manufacturing-operations-europe/ 2016-04-28T15:29:08+00:00 https://ablinc.com/about-abl/news/news-item/transgene-abl-announce-acquisition-abl-europe-transgenes-production-asset/ 2016-04-28T15:55:11+00:00 https://ablinc.com/about-abl/news/news-item/abl-awarded-national-cancer-institute-contract-continue-groundbreaking-retroviral-research/ 2016-06-24T18:41:53+00:00 https://ablinc.com/about-abl/news/news-item/abl-inc-announces-agreements-regenxbio-process-development-scale-clinical-manufacturing-rgx-501/ 2016-06-24T20:08:53+00:00 https://ablinc.com/about-abl/news/news-item/sillajen-announces-commercial-manufacturing-agreement-abl-europe-lead-oncolytic-virus-pexa-vec/ 2016-06-24T20:38:56+00:00 https://ablinc.com/about-abl/news/news-item/advanced-bioscience-laboratories-selected-nhlbi-biologics-manufacturing-facility-new-smartt-program/ 2016-07-14T16:35:40+00:00 https://ablinc.com/about-abl/news/news-item/abl-inc-awarded-nih-contract-nhp-core-quantitative-viral-rna-laboratory-aids-vaccine-research-development/ 2016-07-14T16:36:00+00:00 https://ablinc.com/about-abl/news/news-item/biowatch-abl-turns-50-new-digs-open-house/ 2016-07-14T16:36:21+00:00 https://ablinc.com/about-abl/news/news-item/washington-post-biotech-consultants-find-fertile-ground-dc-area/ 2016-07-14T16:36:45+00:00 https://ablinc.com/about-abl/news/news-item/contract-pharma-abl-opens-newly-expanded-hq/ 2016-07-14T16:37:03+00:00 https://ablinc.com/about-abl/news/news-item/abl-selected-collaborate-5-year-u19-grant-support-new-research-toward-hiv-cure/ 2016-07-14T16:37:32+00:00 https://ablinc.com/about-abl/news/news-item/abl-completes-validation-new-cgmp-manufacturing-facility/ 2016-07-14T16:37:48+00:00 https://ablinc.com/about-abl/news/news-item/abl-awarded-niaid-preclinical-development-support-contract-maximum-funding-102m-seven-years/ 2016-07-14T16:38:17+00:00 https://ablinc.com/about-abl/news/news-item/abl-launches-new-website/ 2016-07-14T16:38:34+00:00 https://ablinc.com/about-abl/news/news-item/trophogen-selects-abl-contract-manufacturer-recombinant-human-follicle-stimulating-hormone-rhfsh-analog/ 2016-07-14T16:39:12+00:00 https://ablinc.com/about-abl/news/news-item/inviragen-enlists-abl-manufacture-master-virus-seed-stock-plague-vaccine-development/ 2016-07-14T16:39:31+00:00 https://ablinc.com/about-abl/news/news-item/abl-supporting-manufacture-alphacores-rhlcat-protein-nhlbis-smartt-program/ 2016-07-14T16:39:51+00:00 https://ablinc.com/about-abl/news/news-item/abl-provide-cell-line-development-process-development-cgmp-manufacturing-services-scupa-university-texas-health-science-center-tyler/ 2016-07-14T16:40:09+00:00 https://ablinc.com/about-abl/news/news-item/abl-awarded-dmid-biologics-manufacturing-contract-worth-102m/ 2016-07-14T16:40:39+00:00 https://ablinc.com/about-abl/news/news-item/abl-awarded-nih-contract-fund-102m-biologics-manufacturing-characterization-services/ 2016-07-14T16:41:24+00:00 https://ablinc.com/about-abl/news/news-item/abl-announces-additions-manufacturing-quality-control-teams/ 2016-07-14T16:42:31+00:00 https://ablinc.com/about-abl/news/news-item/abl-2012-publications-presentations/ 2016-07-14T16:43:44+00:00 https://ablinc.com/about-abl/news/news-item/abl-recognized-biologics-manufacturing-support-nhlbi-sponsored-ind/ 2016-07-14T16:44:04+00:00 https://ablinc.com/about-abl/news/news-item/abl-president-ceo-dr-thomas-vancott-finalist-executive-year/ 2016-07-14T16:44:32+00:00 https://ablinc.com/about-abl/news/news-item/abl-president-ceo-dr-thomas-vancott-named-finalist-tech-council-maryland-tcm-2013-executive-year/ 2016-07-14T16:45:10+00:00 https://ablinc.com/about-abl/news/news-item/abl-wins-7-year-niaid-simian-vaccine-evaluation-unit-contract/ 2016-07-14T16:46:22+00:00 https://ablinc.com/about-abl/news/news-item/abl-awarded-simian-vaccine-evaluation-unit-sveu-contract-niaid-worth-80m/ 2016-07-14T16:46:53+00:00 https://ablinc.com/about-abl/news/news-item/abl-attend-biodefense-vaccines-therapeutics-summit/ 2016-07-14T16:48:51+00:00 https://ablinc.com/about-abl/news/news-item/dr-maria-grazia-ferrari-spoke-nmrc-mucosal-immunology-research/ 2016-07-14T16:49:15+00:00 https://ablinc.com/about-abl/news/news-item/abl-selected-path-manufacture-novel-shigella-vaccine-candidate/ 2016-07-14T16:49:52+00:00 https://ablinc.com/about-abl/news/news-item/abl-inc-calixar-announce-strategic-marketing-agreement/ 2016-07-14T16:50:39+00:00 https://ablinc.com/about-abl/news/news-item/abl-completes-manufacture-rhabdovirus-based-oncolytic-therapeutic-vaccine-phase-clinical-trial/ 2016-07-14T16:51:03+00:00 https://ablinc.com/about-abl/news/news-item/statement-abl-president-ceo-dr-thomas-vancott-strategic-agreement-bioqual/ 2016-07-14T16:52:54+00:00 https://ablinc.com/about-abl/news/news-item/dr-thomas-vancott-invited-speak-11th-annual-biologics-forum-tokyo/ 2016-07-14T16:53:21+00:00 https://ablinc.com/about-abl/news/news-item/abl-supports-profectus-biosciences-preclinical-efficacy-studies-subunit-vaccine-hiv-ihv001/ 2016-07-14T16:53:39+00:00 https://ablinc.com/about-abl/news/news-item/abl-inc-acquires-majority-interest-platine-pharma-services/ 2016-07-14T16:54:16+00:00 https://ablinc.com/about-abl/news/news-item/expression-therapeutics-selects-abl-development-hemophilia-factor-viii-therapy/ 2016-07-14T16:54:34+00:00 https://ablinc.com/about-abl/news/news-item/abl-named-small-business-champion-montgomery-county/ 2016-07-20T14:39:29+00:00 https://ablinc.com/about-abl/news/news-item/division-aids-awards-abl-seven-year-contract-provide-hiv-microbicide-research-product-development-support/ 2016-07-26T14:06:29+00:00 https://ablinc.com/about-abl/news/news-item/abl-awarded-subcontract-production-inactivated-zika-virus-vaccine/ 2016-08-04T12:46:30+00:00 https://ablinc.com/about-abl/news/news-item/abl-awarded-niaid-contract-develop-biotherapeutics-address-infectious-disease/ 2016-09-21T12:34:37+00:00 https://ablinc.com/about-abl/news/news-item/abl-inc-offers-quanterix-diagnostic-platform-ultrasensitive-biomarker-detection-platine-pharma-services-subsidiary/ 2016-12-19T17:52:50+00:00 https://ablinc.com/about-abl/news/news-item/abl-nominated-two-vaccine-industry-excellence-awards-best-cmo-best-cro/ 2017-02-22T17:25:28+00:00 https://ablinc.com/about-abl/news/news-item/abl-awarded-barda-contract-fill-live-virus-based-medical-countermeasures/ 2017-04-05T14:19:26+00:00 https://ablinc.com/about-abl/news/news-item/national-center-advancing-translational-sciences-ncats-awards-abl-5-year-therapeutic-development-manufacturing-contract/ 2017-04-19T12:45:26+00:00 https://ablinc.com/about-abl/news/news-item/abl-increases-aseptic-fillfinish-capacity-state-art-fully-automated-vial-filling-line/ 2017-05-11T13:18:45+00:00 https://ablinc.com/about-abl/news/news-item/abl-inc-finalist-maryland-tech-council-life-science-company-year/ 2017-05-17T18:17:42+00:00 https://ablinc.com/about-abl/news/news-item/abl-awarded-nih-contract-hiv-vaccine-development-worth-318-million/ 2017-07-20T13:06:42+00:00 https://ablinc.com/about-abl/news/news-item/abl-europe-sillajen-expand-strategic-manufacturing-collaboration-oncolytic-virus-therapies/ 2018-01-23T18:22:42+00:00 https://ablinc.com/about-abl/news/news-item/abl-europe-enters-collaboration-gmp-manufacture-hookipa-biotechs-heterologous-viral-vector-immunotherapy-platform/ 2018-02-27T15:10:32+00:00 https://ablinc.com/about-abl/news/news-item/najit-technologies-partners-abl-development-novel-vaccine-platform/ 2018-03-05T18:44:49+00:00 https://ablinc.com/about-abl/news/news-item/sartorius-stedim-biotech-supports-abl-europe-successful-completion-viral-vector-gmp-capacity-expansion/ 2018-03-20T20:20:48+00:00 https://ablinc.com/about-abl/news/news-item/abl-inc-announces-hiring-marykay-marchigiani-chief-financial-officer/ 2018-06-05T18:00:48+00:00 https://ablinc.com/about-abl/news/news-item/abl-inc-announces-hiring-of-jarlath-keating-as-chief-commercial-officer/ 2018-09-26T15:06:50+00:00 https://ablinc.com/about-abl/news/news-item/abl-awarded-long-running-national-cancer-institute-contract-to-continue-groundbreaking-retroviral-research/ 2018-10-04T14:32:23+00:00 https://ablinc.com/about-abl/news/news-item/abl-inc-announces-appointment-of-jarlath-keating-as-president-and-chief-executive-officer/ 2018-11-13T18:11:08+00:00 https://ablinc.com/about-abl/news/news-item/abl-expands-gmp-viral-vector-manufacturing-capacity-with-state-of-the-art-facility-acquisition-in-lyon-france/ 2019-01-16T17:12:20+00:00 https://ablinc.com/about-abl/news/news-item/abl-inc-awarded-multiple-award-idiq-contract-to-provide-cgmp-manufacturing-services-in-support-of-the-prevent-cancer-preclinical-cancer-prevention-program-first-manufacturing-task-order-aw/ 2019-10-14T13:29:49+00:00 https://ablinc.com/about-abl/news/news-item/abl-inc-supports-fill-finish-of-sars-cov-2-covid-19-vaccine-candidate/ 2020-04-15T18:00:36+00:00 https://ablinc.com/about-abl/news/news-item/abl-continues-to-support-race-to-find-a-cure-sars-cov-2-covid-19-vaccine-candidate/ 2020-05-04T15:46:04+00:00 https://ablinc.com/about-abl/news/news-item/themis-collaborates-with-abl-europe-to-manufacture-its-sars-cov-2-vaccine-candidate-in-france/ 2020-05-11T17:16:40+00:00 https://ablinc.com/about-abl/news/news-item/just-evotec-biologics-partners-with-abl-on-development-of-broadly-neutralising-antibody-against-hiv/ 2020-06-08T14:48:10+00:00 https://ablinc.com/about-abl/news/news-item/abl-europe-university-clinic-of-tuebingen-and-prime-vector-technologies-partner-for-a-2nd-generation-covid-19-vaccine/ 2020-11-05T21:05:22+00:00 https://ablinc.com/about-abl/news/news-item/abl-awarded-nih-contract-for-continued-support-of-hiv-vaccine-development/ 2022-10-20T18:14:51+00:00 https://ablinc.com/about-abl/news/news-item/abl-awarded-multimillion-contract-to-provide-manufacturing-and-nonclinical-services-to-support-development-of-promising-therapeutics-for-the-ninds/ 2022-11-04T13:46:55+00:00 https://ablinc.com/about-abl/news/news-item/abl-awarded-seven-year-nih-contract-for-continued-support-in-hiv-prevention-products/ 2023-05-23T14:00:40+00:00 https://ablinc.com/about-abl/news/news-item/abl-enters-seven-year-multimillion-dollar-contract-with-nih-for-diagnostics-preclinical-services-program/ 2023-07-17T09:00:08+00:00 https://ablinc.com/about-abl/news/news-item/abl-appoints-lauren-hudacik-as-president-and-chief-executive-officer-of-abl-inc/ 2023-11-17T16:01:31+00:00 https://ablinc.com/about-abl/news/news-item/an-interview-with-lauren-hudacik-abl-incs-new-ceo/ 2023-12-13T19:22:00+00:00 https://ablinc.com/about-abl/news/news-item/advanced-bioscience-laboratories-inc-abl-selected-as-member-of-arpa-h-investor-catalyst-hub-spoke-network/ 2024-02-22T15:45:43+00:00 https://ablinc.com/about-abl/news/news-item/advanced-bioscience-laboratories-inc-receives-a-three-year-contract-under-the-idiq-from-nih-national-institute-of-neurological-disorders-and-stroke-ninds/ 2024-03-27T17:43:48+00:00 https://ablinc.com/about-abl/news/news-item/advanced-bioscience-laboratories-inc-receives-a-multi-year-funding-under-the-idiq-from-nih-national-institute-of-neurological-disorders-and-stroke-ninds-to-support-the-helping-end-addiction-long-t/ 2024-03-27T17:56:52+00:00 https://ablinc.com/about-abl/news/news-item/abl-awarded-subcontract-to-support-immunogenicity-testing-of-gene-therapy-products-for-rare-diseases/ 2024-04-26T20:05:28+00:00 https://ablinc.com/about-abl/news/news-item/advanced-bioscience-laboratories-inc-awarded-two-2-multi-year-idiqs-from-the-national-institutes-of-health-nih-national-center-for-advancing-translational-sciences-ncats/ 2024-08-27T14:54:24+00:00 https://ablinc.com/about-abl/news/news-item/abl-awarded-six-6-new-nih-task-orders-under-rapps-contract-to-provide-expanded-support-of-hiv-prevention-products-in-the-pediatric-population/ 2024-10-28T12:54:17+00:00 https://ablinc.com/about-abl/news/news-item/ascend-advanced-therapies-merges-with-abl-to-expand-united-states-capacity-and-capabilities/ 2024-11-13T21:43:33+00:00 https://ablinc.com/about-abl/news/news-item/abl-demonstrates-breakthrough-manufacturing-approach-that-cuts-hiv-vaccine-production-timeline-by-two-thirds/ 2025-08-21T14:58:51+00:00